Frank Neumann's most recent trade in Verastem Inc was a trade of 300,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 6, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Verastem Inc | Frank Neumann | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Verastem Inc | Frank Neumann | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 150,000 | 150,000 (0%) | 0% | 0 | Common Stock |